Akums Drugs to host virtual analyst conference call on May 18, 2026, to discuss Q4 FY2026 results and audited financials.
Management participants include MDs Sanjeev Jain and Sandeep Jain, CFO Sumeet Sood, and Head Strategy Sahil Maheshwari.
Company explicitly states no unpublished price sensitive information will be shared during the investor meet.